Medifast Inc (MED) financials

NYSE · Consumer Staples

$12.15 -0.90% Close Oct 30, 2026 Live

Medifast revenue and earnings by year

Medifast's revenue was $386 million in the fiscal year to December 31, 2025, down 36.0% from the year before. Net income was -$18.7 million, -4.8% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 3.9% a year on average.

RevenueNet income
$0$500M$1.00B$1.50B
2016201720182019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 10 fiscal years

In billions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenue0.390.601.071.601.530.930.710.500.300.27
Revenue growth-36.0%-43.8%-32.9%4.8%63.2%31.0%42.4%66.1%9.8%—
Gross profit0.280.440.781.141.130.700.540.380.230.21
Gross margin71.3%73.8%72.4%71.3%73.9%74.6%75.2%75.8%75.5%74.9%
Operating income-0.010.000.130.180.220.130.090.070.040.03
Operating margin-3.7%0.5%11.8%11.6%14.2%14.4%12.8%13.8%13.1%9.8%
Net income-0.020.000.100.140.160.100.080.060.030.02
Net margin-4.8%0.3%9.3%9.0%10.7%11.0%10.9%11.1%9.2%6.5%
Diluted EPS-$1.70$0.19$9.10$12.73$13.89$8.69$6.43$4.61$2.29$1.50
Free cash flow0.000.020.140.180.060.140.070.060.040.02

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open MED in Markets.

See also: MED valuation and P/E history · MED returns

No forecast, no recommendation. This page describes Medifast Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.